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ABSTRACT Local anesthetics are known to inhibit neuronal fast anterograde axoplasmic transport (FAAT) in a reversible and
dose-dependent manner, but the precise mechanism has not been determined. FAAT is powered by kinesin superfamily
proteins, which transport membranous organelles, vesicles, or protein complexes along microtubules. We investigated the
direct effect of local anesthetics on kinesin, using both in vitro motility and single-molecule motility assays. In the modified
in vitro motility assay, local anesthetics immediately and reversibly stopped the kinesin-based microtubule movement in an
all-or-none fashion without lowering kinesin ATPase activity. QX-314, a permanently charged derivative of lidocaine, exerted
an effect similar to that of lidocaine, suggesting that the effect of anesthetics is due to the charged form of the anesthetics.
In the single-molecule motility assay, the local anesthetic tetracaine inhibited the motility of individual kinesin molecules in a
dose-dependent manner. The concentrations of the anesthetics that inhibited the motility of kinesin correlated well with those
blocking FAAT. We conclude that the charged form of local anesthetics directly and reversibly inhibits kinesin motility in a
dose-dependent manner, and it is the major cause of the inhibition of FAAT by local anesthetics.
INTRODUCTION
In addition to their anesthetic effects on excitable cell mem-
branes, local anesthetics are known to affect a variety of
cellular motile functions. They inhibit fast anterograde axo-
plasmic transport (FAAT) (Aasheim et al., 1974; Fink et al.,
1972; Fink and Kish, 1976; Lavoie, 1982a,b, 1983; Lavoie
et al., 1989), neurite outgrowth (Anderson and Bamburg,
1981), the motility of cilia (Manawadu et al., 1978), inflam-
matory responses such as chemotaxis or leukocyte migra-
tion (Cullen and Haschke, 1974; Sasagawa, 1991), phago-
cytosis (Cullen and Haschke, 1974), exocytosis (Banerjee
and Redman, 1977), the endocrine system (Eichhorn and
Peterkofsky, 1979; Kawabata et al., 1993), and cell prolif-
eration (Martinsson et al., 1993). These effects are unrelated
to the ability of local anesthetics to block the conduction of
nerve impulses, and the precise mechanisms have not been
determined (Lavoie et al., 1989).
Motility for all of these events depends on motor proteins,
i.e., actomyosin, kinesin, and dynein superfamily proteins. It
has been shown that local anesthetics directly inhibit actomy-
osin motility in vitro (Tsuda et al., 1996). Thus an inhibition of
the motility of these motor proteins could be a unifying mech-
anism for the various inhibitory effects of local anesthetics.
FAAT is inhibited by local anesthetics in a reversible and
dose-dependent manner (Fink and Kish, 1976). FAAT is
powered by kinesin superfamily proteins, which transport
membranous organelles, vesicles, or protein complexes
along microtubules (MTs) by utilizing the chemical energy
of ATP hydrolysis (Hirokawa, 1998). Therefore, local an-
esthetics might affect kinesin, MTs, the energy supply, or
even other, unknown factors. At the concentration that leads
to the inhibition of axoplasmic transport, local anesthetics
neither depolymerize MTs (Byers et al., 1973, 1979; Fink et
al., 1972; Lavoie et al., 1989) nor decrease the intracellular
ATP or creatine phosphate as much as they inhibit FAAT
(Banerjee and Redman., 1977; Lavoie et al., 1989). There-
fore, the present study was designed to examine whether
local anesthetics directly inhibit kinesin motility. In vitro
motility assays (Vale et al., 1985) and a single-molecule
imaging technique (Funatsu et al., 1995; Vale et al., 1996)
have elucidated the mechanism by which local anesthetics
act on individual single kinesin molecules to inhibit FAAT.
MATERIALS AND METHODS
Chemicals
Lidocaine hydrochloride (2-diethylamino-N-[2,6-dimethylphenyl]acetamide)
and tetracaine hydrochloride (4-[butylamino]benzoic acid 2-[di-
methylamino]ethyl ester) were purchased from Sigma Chemical Co. (St.
Louis, MO). QX-314, a quaternary derivative of lidocaine (N-(2, 6-dimethyl-
phenylcarbamoylmethyl)triethylammonium bromide), which has a permanent
positive charge, was obtained from Funakoshi Co. (Tokyo, Japan), and HEPES
was purchased from Dojindo (Kumamoto, Japan). All of the other chemicals
were of reagent grade or higher (Wako Pure Chemicals, Osaka, Japan). All of
the solutions were made with distilled deionized water.
Bovine brain kinesin and rhodamine- or
Cy5-labeled MT
Bovine kinesin and tubulin were purified from fresh bovine brain by MT
affinity purification, followed by DEAE chromatography and sedimenta-
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tion, as described previously (Kojima et al., 1997). Microtubule-associated
protein (MAP)-free tubulin was prepared by the method of Williams et al.
(Williams and Lee, 1982), with some modification (Haimo and Fenton,
1988). Tubulin was labeled with either tetramethylrhodamine (TMR) (C-
1171; Molecular Probes) or Cy5 monofunctional dye (PA25001; Amer-
sham Life Science, Arlington Heights, IL) (Hyman et al., 1991). Fluores-
cent MTs were prepared by copolymerization of labeled and unlabeled
tubulin at a molar ratio of 1:62 and 1:72 for TMR-labeled tubulin and
Cy5-labeled tubulin, respectively. For assays, MTs with a length of 5–15
m were prepared, using a short segment of polymer as a seed for
polymerization (Mitchison and Kirschner, 1984). Polymerization was per-
formed in 80 mM 2-(N-morpholino)ethanesulfonic acid (pH 6.8), 1 mM
MgSO4, 1 mM EGTA, 1 mM GTP at 35°C for 30 min, and the MT was
stabilized by the addition of 0.1 mM taxol (T-7402; Sigma Chemical Co.).
Fluorescently labeled kinesin
We used human kinesin that was truncated just before the hinge, at residue
560, and a short peptide containing a reactive cysteine was introduced at its
C-terminus (uhK560Cys) (Vale et al., 1996). UhK560Cys expressed in
Escherichia coli, BL21(DE3)plysS, was purified and labeled at cysteine
with Cy3-maleimide, which was obtained by linking Cy3-OSu (PA-23001;
Biological Detection Systems) to N-(2-(1-piperazinyl)ethyl) maleimide.
The stoichiometry of labeling was 1.26 dyes per polypeptide chain, as
determined from the fluorescent intensity of individual kinesin spots and
their photobleaching pattern in total internal reflection microscopic images
(Funatsu et al., 1995; Vale et al., 1996).
Observation under conventional
fluorescence microscope
For the in vitro motility assays, fluorescent MTs were imaged using a
conventional inverted fluorescence microscope (TMD; Nikon. Co., Tokyo,
Japan) with an oil-immersion objective lens (Neofluar,100, N. A. 1.3;
Carl Zeiss, Jena, Germany). The fluorescence images were projected onto
a silicon-intensifier target tube (SIT) camera (Hamamatsu C-2400-08;
Hamamatsu Photonics, Shizuoka, Japan) and stored in a video cassette
recorder. The lengths and the sliding velocities of individual MTs were
quantified with an image processor (TVIP4100; Avionics, Tokyo, Japan).
Observation under total internal
reflection microscope
For the single-molecule motility assay, fluorescent single kinesin mole-
cules were imaged using low background total internal reflection micro-
scope (Funatsu et al., 1995, 1997; Vale et al., 1996). To visualize single
kinesin molecules and fluorescent MTs simultaneously, we introduced a
dual-view optics into the microscope (Kinosita et al., 1991) (Fig. 1 a). The
FIGURE 1 (a) The optical system of low background total internal reflection microscopy equipped with dual-view optics. Images of fluorescent single
kinesin molecules and fluorescent MTs are projected side by side on the photocathode of the image intensifier so that they can be observed simultaneously.
(b) Images of Cy3-labeled single kinesin molecules (Cy3-uhK560Cys) (left) and a Cy5-labeled MT (right) displayed on the monitor simultaneously. Four
kinesin molecules are seen on the track of the MT (indicated between the two arrowheads). Scale bar, 10 m.
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fluorescence from the specimen was split by a dichroic mirror (Sigma
Koki, Saitama, Japan) (DM1 in Fig. 1 a) into two, with a separation
wavelength of 630 nm. The two beams were bandpassed filtered (570DF30
for Cy3 and 680DF55 for Cy5; Omega) to exclusively transmit the fluo-
rescence. They were then passed through another dichroic mirror (DM2),
and the two separate images were focused on the focal plane of an image
intensifier (VS4-1845; Video Scope International, Sterling, VA) coupled to
an SIT camera (Hamamatsu C-2400-08; Hamamatsu Photonics) and re-
corded with a video cassette recorder. The imaging was performed at an
excitation laser power of 46 mW and an illumination area of 250  110
m2 (1/e2 value). The incident angle of the beam to the norm at the
interface was 68°.
Standard in vitro motility assay (kinesin
molecules are densely adsorbed)
A coverslip (9 mm  9 mm; Matsunami Co., Kishiwada, Japan) was
placed on the center of another coverslip (24 mm 32 mm; Iwaki Co.) via
two strips of double-coated tape to make a flow chamber (9 mm 5 mm
110 m). Bovine brain kinesin was diluted to a density of 11 g/ml (28.2
nM, calculated from the molecular mass of 390 kDa; Kuznetsov et al.,
1988) with modified BRB80 buffer (M-BRB80; 80 mM HEPES, 2 mM
MgCl2, 1 mM EGTA, pH 7.4, ionic strength 0.1 M). For pH 6.4 and 6.8,
piperazine-N,N-bis(2-ethanesulfonic acid was used instead of HEPES.
Five microliters of dilute kinesin was introduced into the flow chamber so
that kinesin molecules would adhere directly to the glass surface. We did
not pretreat the surface of the chamber with blocking proteins (Block et al.,
1990; Howard et al., 1989) before the application of kinesin, to exclude the
possibility of interaction of these blocking agents with local anesthetics.
After a 3-min incubation with kinesin, the chamber was washed with 20 l
of M-BRB80. Then 50 l of an assay solution (LA-M-BRB80, M-BRB80
containing a local anesthetic; pH and the ionic strength were adjusted to the
original values) containing TMR-labeled MTs (15 g/ml), 10 M taxol, 1
mM ATP, and an oxygen scavenger (25 mM glucose, 36 g/ml catalase,
220 g/ml glucose oxidase, 1% 2-mercaptoethanol) (Harada et al., 1990)
was applied to the flow chamber. In the LA-M-BRB80 buffer containing
lidocaine, 80 mM HEPES (or piperazine-N,N-bis(2-ethanesulfonic acid)
was reduced to 20 mM to adjust the ionic strength to 0.1 M. Gliding
movements of individual MTs were recorded with a video cassette re-
corder. The length and velocity of individual MTs were measured with a
computer image processor (TVIP4100; Avionics, Tokyo, Japan).
Modified in vitro motility assay (kinesin molecules
are sparsely adsorbed)
Because the movement of vesicles in vivo is powered by only a few kinesin
molecules bound to their surface (Hirokawa, 1982, 1998; Miller and Lasek,
1985), we performed the above assay with a low density of kinesin at pH
7.4, to simulate in vivo conditions. The flow chamber on a coverslip was
prepared as described above. Five microliters of kinesin solution diluted
with M-BRB80 (400 ng/ml  1.1 nM) was introduced into the flow
chamber. After a 3-min incubation with kinesin, the chamber was washed
with 20 l of M-BRB80. Then 50 l of M-BRB80 containing TMR-
labeled MTs (15 g/ml), 10 M taxol, 1 mM ATP, and the oxygen
scavenger was applied. After it was confirmed that more than 50% of the
MTs were gliding, the chamber was washed with 50 l of LA-M-BRB80
containing the same concentrations of TMR-labeled MTs, taxol, ATP, and
the oxygen scavenger. Finally, to test for reversibility, the chamber was
washed again with 50 l of M-BRB80 containing the same concentrations
of TMR-labeled MTs, taxol, ATP, and the oxygen scavenger. The images
of the MTs were recorded, and the length and the velocity of individual
MTs were measured by the computer image processor as described above.
Local anesthetic treatment did not lead to MT depolymerization throughout
our study, because of the MT-stabilizing property of taxol.
Single-molecule motility assay
Quartz glass slides (26 mm  56 mm; Matsunami Co.) were cleaned with
0.2 M KOH, 100% acetone, and air dried. They were subsequently treated
with silicone solution (SL-2, Sigma Co., 5% (v/v) in heptane). Twenty
microliters of Cy5-labeled MT (10 g/ml) in buffer A (20 mM HEPES, 10
mM potassium acetate, 4 mM MgSO4, 2 mM EGTA, 0.2 mM EDTA; pH
7.4; ionic strength 29 mM) containing 10 M taxol was placed on the
silicone-treated quartz glass slide between two strips of thin polyester film
(25 m thickness, 22 mm  2 mm), and immediately covered with a
coverslip (18 mm  18 mm, Matsunami Co.). Thus, a flow chamber was
produced between the quartz glass and the coverslip. After a 5-min incu-
bation to allow the MTs to attach to the surface of the quartz glass, the
chamber was washed with 30 l of casein solution (5 mg/ml) and incu-
bated for another 5 min, to block the nonspecific binding of kinesin
molecules to the surface of the quartz glass. The chamber was subsequently
washed with 50 l of buffer A containing 1 mM ATP and 10 M taxol.
Finally, 30 l of kinesin (2 nM uhK560-Cy3) in buffer A containing
tetracaine hydrochloride (pH 7.4, ionic strength 29 mM), 1 mM ATP, 10
M taxol, and the oxygen scavenger was added to the flow chamber. The
polyester sheets were removed, and the flow chamber was sealed with nail
enamel. Under the total internal reflection fluorescence microscope with
dual-view optics, fluorescent images of single kinesin molecules and MTs
were observed and recorded simultaneously at a full video rate (Fig. 1 b).
The location and the MT-based movements of individual kinesin mol-
ecules were quantified from the tape recordings, using a computer image
processor system (Swallow; Inter Quest, Osaka, Japan). Only the move-
ments on long MTs (9–12 m) were measured to minimize the chance that
a Cy3-kinesin would release from a MT simply by running off its end. At
the concentration of kinesin (2 nM), kinesin binding on an individual MT
did not overlap, so that single fluorescent spots could easily be distin-
guished. The number of the association events per minute per micron of
MT was 3.8  0.5, 2.7  0.6, and 3.1  1.1 (mean  SD) for 0, 2.5, and
5 mM tetracaine, respectively, whereas only 0.03  0.01 events per min
were scored on glass without a MT.
The duration of the shot noise of the SIT camera was examined, and its
distribution was fit with a Gaussian curve (0.12  0.06 s, mean  SD). To
minimize the chance of mistaking shot noise for a fluorescent kinesin
molecule, only the fluorescent spots that stayed on the track of the MT for
more than 0.24 s (mean 2 SD of the shot noise) were regarded as kinesin
molecules.
Photobleaching and blinking of fluorescent molecules (Dickson et al.,
1997) and the effect of local anesthetic tetracaine on these processes were
also examined. For these measurements, Cy3-kinesin molecules were
adsorbed directly to a quartz glass slide, and the time required for a single
fluorescent spot to disappear for the first time by either photobleaching or
blinking was examined. The distribution of the disappearance of the
fluorescent spots should decay exponentially (Vale et al., 1996). At the
laser power used in this assay (46 mW), the rate of disappearance (kdis) in
the absence and the presence of 5 mM tetracaine was 0.084  0.001 s1
and 0.080 0.001 s1, respectively. In the single-molecule motility assay,
kinesin spots moving along a MT disappeared at 0.77  0.02 s1 and
1.64  0.04 s1 in the absence and the presence of 5 mM tetracaine,
respectively (kobs; observed rate of disappearance). They were significantly
larger than the kdis values for kinesin attached to glass. Thus no correction
was required for photobleaching and blinking. From the kobs and kdis, the
actual run length of the motor in the absence of Cy3 photobleaching and
blinking, krel (motor release constant), could be calculated from the equa-
tion kobs  krel  kdis (Romberg et al., 1998). We did not correct the data
using this equation because kdis values were small. All of the experiments,
including the in vitro motility assay, were performed at 25°C.
ATPase measurements
Microtubule-activated ATPase activity of kinesin (uhK560) was measured
at 25°C in buffer A containing tetracaine (pH 7.4, ionic strength 29 mM)
or in M-BRB80 containing lidocaine or QX-314 (pH 7.4, ionic strength
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100 mM). Ten micromolar taxol and 1 mM dithiothreitol (DTT) were
added to the buffers. The reaction was initiated by the addition of 2 mM
ATP and terminated with the addition of perchloric acid. Inorganic Pi was
detected by the modified malachite green method (Ohno and Kodama,
1991). MT-activated ATPase activity of unlabeled kinesin (uhK560) has
been demonstrated to be similar to that of Cy3-labeled kinesin (uhK560-
Cy3) (Vale et al., 1996). Neither chemical reactions of the assay nor the
absorbance of malachite green at 650 nm was affected by the anesthetic.
The values of kcat and K0.5,MT were determined from the hyperbolic fit.
RESULTS
Dose-dependent decrease in MT gliding velocity
by local anesthetics in the standard in vitro
motility assay
In the standard in vitro motility assay, the gliding velocity of
MTs decreased as the concentration of the anesthetics in-
creased (Figs. 2, a and b), and the effect was totally revers-
ible. The measure of the inhibitory potency of the anesthet-
ics, the decrease in MT gliding velocity (% per mM
anesthetic), at pH 7.4 was only 1.5 times greater than that at
pH 6.4 in the case of tetracaine and only 1.2 times greater in
the case of lidocaine (see Discussion). All of the MTs on the
surface moved smoothly and continuously, even in the
presence of the anesthetics. These effects are not large enough
to explain the inhibition of FAAT by local anesthetics.
Local anesthetics stop the gliding of MTs in the
modified in vitro motility assay (kinesin molecules
are sparsely adsorbed)
A single kinesin molecule can move a MT for several
micrometers as quickly as several kinesin molecules can
(Howard, 1996). In the standard in vitro assay described
above, gliding movement of a MT is supported by many
kinesin molecules. The number of kinesin molecules, the
motility of which is affected by the anesthetics, would
fluctuate around the equilibrium. Therefore, it is possible
that even if the motility of the majority of kinesin molecules
is affected, a small number of remaining intact molecules
could still move the MT; i.e., an inhibitory effect of local
anesthetics on a subset of kinesin could be dulled by the
remaining kinesin molecules with intact motility. We ex-
amined this possibility by observing the effects of local
anesthetics on MT gliding movements, which are supported
by only a few kinesin molecules.
In this experiment, kinesin molecules were sparsely ad-
sorbed to the coverslip as described. Because of the low
density of kinesin, only a few kinesin molecules would be
expected to interact with a MT; thus not all of the MTs
glide, even in the absence of an anesthetic. When a buffer
containing a local anesthetic (5 mM tetracaine hydrochlo-
ride, 50 mM lidocaine hydrochloride, or 50 mM QX-314)
was applied to the sample, almost all of the MTs immedi-
ately stopped gliding (Fig. 3, a-c). When the anesthetic was
removed by applying the control buffer, most MTs recov-
ered their motility instantaneously. The velocity of gliding
MTs after the removal of the anesthetic did not differ from
that before the application of the anesthetic, indicating the
full reversibility of the effect (Table 1). The length of the
MTs examined for the analysis did not differ among the
three states (before the application of an anesthetic, in the
presence of the anesthetic, and after the removal of the
anesthetic). The effect of QX-314, a permanently charged
derivative of lidocaine, was similar to that of lidocaine (Fig.
3 c).
At the concentrations lower than those described above
(1, 2, 3, and 4 mM for tetracaine; 10, 20, 30, and 40 mM for
FIGURE 2 The gliding velocity of MTs in the standard in vitro motility
assay, in the presence of (a) tetracaine and (b) lidocaine at various levels
of pH. Bovine brain kinesin was used in this assay. In the case of tetracaine,
the decrease in MT gliding velocity (% per mM anesthetic) was 2.5 and 1.7
for pH 7.4 and pH 6.4, respectively. In the case of lidocaine, it was 0.29,
0.23, and 0.24 for pH 7.4, pH 6.8, and pH 6.4, respectively. Gliding
velocity was measured only for the MTs that moved continuously for more
than15 s and averaged for 50–100 different MTs in each experiment. The
entire experiment was performed at 25°C. Declined velocities were recov-
ered to the original levels by the removal of the anesthetics. Bars, SD.
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lidocaine and QX-314), local anesthetics exerted no signif-
icant effects on MT gliding. Thus the effect was in an
all-or-none fashion with a certain threshold (50 mM for
lidocaine and QX-314, 5 mM for tetracaine).
Local anesthetic tetracaine suppresses the
movement of individual single kinesin molecules
in a dose-dependent manner
Although the local anesthetics inhibited the kinesin-based
MT gliding in an all-or-none fashion in the above experi-
ment, these results do not necessarily imply that they inhibit
the motility of individual kinesin molecules in an all-or-
none fashion. An all-or-none inhibition of MT gliding
movement could have resulted from the nature of the ex-
perimental system (see Discussion).
Therefore, the effect of the local anesthetic tetracaine on
the movements of single kinesin molecules was directly
examined by using the single molecule motility assay. For
individual kinesin molecules, the duration of interaction
with a MT and the travel distance before release from the
MT were measured (Fig. 4, a–c). The distributions of the
travel distance were fitted with single-exponential decays
(Fig. 4, a–c, insets), which gave the mean travel distances
(decay constant B in the figure legend). Tetracaine de-
creased the travel distance in a dose-dependent manner (Fig.
4 d), and the concentration of tetracaine that decreases the
mean travel distance to 1/e (KI) was 5.1 mM. In the presence
of 5 mM tetracaine, most of the molecules bound to the MT
showed little motility, matching the result of the modified in
vitro motility assay, in which 5 mM tetracaine was exactly
the threshold at which microtubule gliding stopped (Fig. 3
a). The KI values of lidocaine and QX-314 would be also
similar to the thresholds at which microtubule gliding
stopped, 50 mM.
The rate of binding of uhK560 to the MT was not sig-
nificantly influenced by tetracaine. The number of the as-
sociation events per minute per micrometer of MT was
3.8 0.5, 2.7 0.6, and 3.1 1.1 (mean SD) for 0, 2.5,
and 5 mM tetracaine, respectively (10-min observation for
each MT). The rate of dissociation of kinesin from the MT
(the reciprocal of the duration of interaction with a MT) was
doubled by the presence of 5 mM tetracaine (0.77  0.02
s1 and 1.64  0.04 s1 in the absence and in the presence
of 5 mM tetracaine, respectively).
Local anesthetics do not interfere with the
ATPase activity of kinesin
Because kinesin moves along a MT by using the free energy
liberated by the hydrolysis of ATP, the effect of local
anesthetics on the MT-activated kinesin ATPase activity
was investigated. Neither kcat nor K0.5,MT of uhK560 was
affected by the presence of the anesthetics at the concen-
trations that promote maximum inhibition of kinesin motil-
ity (Fig. 5).
TABLE 1 Velocity of gliding MTs and the length of
examined MTs
Velocity of gliding
MTs (m/s)
Length of
MTs (m)
Tetracaine
0 mM 0.84  0.25* 5.3  2.8‡
0 ➡ 5 mM — 5.9  2.9‡
5 ➡ 0 mM 0.89  0.23* 5.5  3.0‡
Lidocaine
0 mM 0.89  0.23† 5.7  3.0§
0 ➡ 50 mM — 6.2  2.9§
50 ➡ 0 mM 0.85 0.17† 6.0  2.9§
QX-314
0 mM 0.95  0.19¶ 6.1  2.9
0 ➡ 50 mM — 6.0  2.8
50 ➡ 0 mM 0.90 0.10¶ 6.9  2.7
Note: Values are mean  SD.
*, †, ‡, §, p 	 0.1 (Student’s t-test).
¶, , p 	 0.01 (Student’s t-test).
FIGURE 3 The proportion of gliding MTs in the modified in vitro motility assay, in the presence of (a) tetracaine, (b) lidocaine, and (c) QX-314. Bovine
brain kinesin was used in this assay. The initial percentage of gliding MTs depends on the concentration of kinesin that adhered onto the coverslip. The
actual number of MTs examined is provided above the respective data.
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DISCUSSION
Local anesthetics prevent kinesin from
moving forward
There are three possible mechanisms by which kinesin-
based MT gliding could be affected by local anesthetics.
Local anesthetics might 1) dissociate kinesin-MT complex,
2) lower the velocity of individual kinesin molecules, or 3)
stop the movement of kinesin without dissociating it from
the MT.
In the standard in vitro motility assay with a relatively
high density of kinesin on the coverslip, the gliding velocity
of MTs was decreased by local anesthetics in a dose-
dependent manner (Fig. 2). If the anesthetics were only to
dissociate the kinesin-MT complex, the number of intact
kinesin molecules interacting with a MT would have de-
creased, but the MT gliding velocity would not have de-
creased, because the remaining unaffected kinesin mole-
cules could move the MT at normal velocity (Howard et al.,
1989). Thus our result implies that anesthetics either lower
the velocity of individual kinesin molecules in a dose-
dependent manner or prevent kinesin from moving forward
without dissociating it from the MT, imposing a little drag
on the MT gliding movement. To test these two possibili-
ties, we had to lower the number of kinesin molecules
participating in the movement of a MT. Another reason to
lower the number of kinesin molecules is that the standard
motility assay does not mimic the in vivo situation well. The
movement of vesicles in vivo is powered by only a few
kinesin molecules bound to their surface (Hirokawa, 1982,
1998; Miller and Lasek, 1985), whereas in the standard
motility assay, a large number of kinesin molecules are
involved in the movement of a single MT.
In the modified in vitro motility assay with low density of
kinesin on the coverslip, local anesthetics stopped the glid-
ing movement of MTs in an all-or-none fashion. If the
FIGURE 4 (a–c) The travel distance of individual kinesin molecules
(Cy3-uhK560Cys) on a MT before being released from it and their duration
of interaction with the MT in the presence of (a) 0 mM, (b) 2.5 mM, and
(c) 5 mM tetracaine. Each open circle represents the data for a single
kinesin molecule. Inset: The distribution of travel distance of individual
kinesin molecules. The vertical axis indicates the proportion to the total
number of the molecules investigated. The distributions were fitted with
exponential decays:
Proportion Ae(Distance[m])/B
where B indicates the decay constant for the travel distance. Tetracaine
decreased the constant B in a dose-dependent manner: 0.152  0.014 m,
0.082  0.006 m, and 0.057  0.002 m for 0 mM, 2.5 mM, and 5 mM
tetracaine, respectively. In the presented experiments, 378, 245, and 376
molecules were retained for analysis for 0 mM, 2.5 mM, and 5 mM
tetracaine, respectively (see text). (d) The mean travel distance of individ-
ual single kinesin molecules (the decay constant B) plotted as a function of
tetracaine concentration. It was fitted with a single exponential curve, and
the decay constant was 5.1 mM. Bars, SD.
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anesthetics only dissociated the kinesin-MT complex, MTs
would have been dissociated from the kinesin-coated sur-
face, instead of being stopped. If they lowered the velocity
of individual kinesin molecules in a dose-dependent man-
ner, the gliding velocity of MTs would have been gradually
lowered, instead of being abruptly stopped. Thus these data
suggest that local anesthetics prevent kinesin from moving
forward without completely dissociating it from the MT.
In the single-molecule motility assay, we observed that
the distance that a kinesin could move along a MT de-
creased as the concentration of tetracaine increased, and
almost all of the motion was abolished at 5 mM tetracaine,
matching the result we obtained with the modified in vitro
motility assay. Although the dissociation rate of individual
kinesin molecules from a MT (the reciprocal of the duration
of interaction with the MT) was doubled by 5 mM tetra-
caine, the dissociation rate of the MT from the kinesin-
coated glass would not be doubled, because under this
condition there is more than one kinesin molecule attached
to the MT.
Charged form of local anesthetics is responsible
The ratio of the charged form to the uncharged form of a
tertiary amine local anesthetic is given by the Henderson-
Hasselbalch equation,
pKa pH log
[BH]
[B]
where [BH] and [B] are the concentrations of the charged
and the uncharged forms, respectively. The pKa values for
tetracaine and lidocaine are, respectively, 8.59 and 8.19 at
25°C (Kamaya et al., 1983). Thus 93.9% of tetracaine and
86.1% of lidocaine are charged at pH 7.4, and as the pH
increases from 6.4 to 7.4, the uncharged form of the anes-
thetics increases by ninefold. However, in the standard in
vitro motility assay, the inhibition of MT gliding by in-
creases in the concentration of the anesthetics changed only
1.5 times at maximum with this change in pH, implying that
the inhibitory effect was not due to the uncharged form of
the anesthetics.
In the modified in vitro motility assay, the inhibition of
motility by QX-314 (Fig. 3 c) suggested that the charged
form of local anesthetics is responsible for inhibiting kine-
sin motility. This contrasts with the result obtained with
actomyosin, despite the structural similarity to kinesin
(Howard, 1997; Kull et al., 1996); myosin-based actin mo-
tility is interfered with by the uncharged form of local
anesthetics (Tsuda et al., 1996).
FIGURE 5 Microtubule-activated ATPase activity of kinesin (uhK560Cys) measured at 25°C in buffer A (a–b, pH 7.4, ionic strength 29 mM) or in
M-BRB80 (c–e, pH 7.4, ionic strength 100 mM). The values of kcat and K0.5,MT were determined from the hyperbolic fit. The difference in K0.5,MT between
a–b and c–e is due to the difference in the ionic strength.
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When a more uncharged form is present, local anesthetics
have been reported to be more potent in blocking FAAT
(Lavoie, 1982b), contrasting with our result. When an an-
esthetic is applied to the neuronal cell, the charged form
cannot go through the membrane, but the uncharged form
penetrates the plasma membrane; thus a new equilibrium
between the charged and uncharged forms must be estab-
lished inside the cell. Therefore, the uncharged form would
be expected to be more potent when applied to the outside
of the cell. However, inside the cell, our results demonstrate
that the charged form of the anesthetic inhibits kinesin
motility.
Local anesthetics uncouple kinesin’s mechanical
event from its biochemical energy source
From the raw data of Fig. 4 a (0 mM tetracaine), assuming
that a kinesin molecule hydrolyzes one ATP per 8-nm step
(Hua et al., 1997; Schnitzer and Block, 1997) and stationary
kinesin bound to a MT does not hydrolyze ATP, the calcu-
lated rate of ATP hydrolysis of kinesin molecules interact-
ing with the MT is 27.1  0.1 s1/site, which is consistent
with the kcat value of our ATPase measurement (23.1  0.6
s1/site). In contrast, in the presence of 5 mM tetracaine
(from the raw data of Fig. 4 c), the calculated rate of ATP
hydrolysis is 6.69 0.03 s1/site, which is much lower than
our measured kcat (21.1  1.0 s1/site). Thus these results
suggest that local anesthetics uncouple kinesin’s mechanical
event from its biochemical energy source, and as the con-
centration of the anesthetic is increased, the number of
kinesin molecules that hydrolyze ATP without moving for-
ward increases.
Which process of kinesin-MT interaction do local
anesthetics affect?
The charged form of local anesthetics inhibits neither the
binding of kinesin to MTs nor ATP hydrolysis, but rather
uncouples ATP hydrolysis from movement and inhibits
kinesin’s ability to move along a MT. Local anesthetics do
not bind to purified tubulin in vitro (Eichhorn and Peterkof-
sky, 1979), and thus it could be possible that the hydrophilic
structure of kinesin or the hydrophilic interaction between
kinesin and MT is disrupted by the charged form of local
anesthetics.
The mechanism for dimeric kinesin movement along a
MT in a processive manner is controversial (Block, 1998).
The prevailing model for processivity is the so-called hand-
over-hand model, in which the motor remains in continuous
contact with the MT as a result of an alternating interaction
of the two heads (Hackney, 1994; Hirose et al., 1996; Ma
and Taylor, 1997). Although it is not clear whether a hand-
over-hand mechanism is essential for processivity (Okada
and Hirokawa, 1999), at least for the normal motility of
two-headed kinesin, coordinated motion of the two heads is
considered to be important (Jiang et al., 1997; Kozielski et
al., 1997; Romberg et al., 1998).
Several recent models have proposed a mechanochemical
cycle for two-headed kinesin in which a sophisticated com-
munication between its two heads is mediated by the “neck”
region that connects them (Hackney, 1994; Hirose et al.,
1996; Tripet et al., 1997). Three-fifths of the neck region is
believed to unwind during motility to allow the MT-free
head to rotate on its axis (neck) and attach to the next
binding site of the MT after ATP hydrolysis (phosphate
release) (Crevel et al., 1996; Hirose et al., 1995).
A notable feature of the neck region is the placement of
destabilizing residues with low hydrophobicity at the inter-
face of the two heads; 16 of the 33 residues of the region
(residues 338–370 in the human kinesin uhK560) are
charged, and they are highly conserved among species
(Navone et al., 1992). We speculate that the charged form of
local anesthetics might interfere with the interaction among
the charged residues of the neck region and inhibit unwind-
ing, resulting in an inability of the free head to rotate and
step forward. Local anesthetics could inhibit the rotation of
the kinesin molecule, the MT-attached head of which is in
an ADP-bound “weak binding” state. Such a mechanism for
the inhibition of motility is consistent with our results as
follows. 1) If the head cannot move along a MT but under-
goes association-dissociation and hydrolyzes ATP for each
dissociation at a single position on the MT, the ATPase
activity would not be affected. 2) The “weak binding” of a
single kinesin molecule to a MT could impose a slight drag
on movement. In the modified in vitro motility assay, there
are only a few kinesin molecules attached to a MT. Thus
when a local anesthetic, the concentration of which exceeds
a certain threshold, is applied, all of the kinesin molecules
that are attached to a single MT will be affected simulta-
neously, and the gliding movement of the MT suddenly
stops (Fig. 3). Under the threshold, a decrease in the gliding
velocity is hardly observed, because only a few molecules
that are affected by the anesthetic can impose only a little
drag on MT gliding movement. Therefore the effect of an
anesthetic appeared in an all-or-none fashion. On the con-
trary, in the standard assay in which kinesin is densely
adsorbed, a large number of kinesin molecules that are
attached to a single MT are affected by local anesthetics.
They impose a larger drag on MT gliding movement, which
is proportional to the number of affected kinesin molecules;
thus a dose-dependent decrease in the MT gliding velocity
is observed (Fig. 2).
Single-molecule motility assay, beads movement
assay, and FAAT
Organelle and vesicle transport in vivo, FAAT, is so effi-
cient that individual particles can move at their maximum
rate of transport almost continuously for many hours and
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over distances of many centimeters (Brady, 1984). Reduc-
tion in the number of intact kinesin molecules per particle
surface leads either to its failure to bind to a MT or to
nonsuccessive movement on a MT (Block et al., 1990),
which means a decrease in the amount of FAAT.
In our single-molecule motility assay, kinesin molecules
that could not move on a MT increased as the concentration
of tetracaine increased. This result is equivalent to the
decrease in the number of intact kinesin molecules per
particle surface, which leads to the inhibition of FAAT.
Furthermore, tetracaine doubled the dissociation rate of
individual kinesin molecules from the MT (the reciprocal of
the duration of interaction with a MT), which would also
lead to an inhibition of FAAT. Therefore, our results imply
that the inhibition of FAAT by local anesthetics is due to an
inhibition of kinesin motility.
Comparison with the whole cell study
The concentrations of the anesthetics that inhibited kinesin
motility correlate well with those previously reported to
block FAAT, although a precise comparison is difficult
because of differences in experimental conditions.
In our experiments, 5 mM tetracaine or 50 mM lidocaine
(25°C, pH 7.4, ionic strength 100 mM) inhibited the motil-
ity of kinesin molecules almost completely. Whereas in
whole cell studies, 1 mM tetracaine (25°C, pH 7.1) pro-
duced 80% inhibition of the transport (Lavoie, 1982b),
and 22.2 mM lidocaine (38.5°C, pH 7.48) produced approx-
imately 90% inhibition of transport(Fink et al., 1972). These
investigators (Fink and Kish, 1976) have also reported that
20 to 30 mM lidocaine had almost completely abolished the
FAAT in the trigeminal nerve of rats in vivo. Thus, there is
a good agreement between the results from whole cell and
individual molecules, and these trivial differences may be
due to the difference in experimental conditions (pH, tem-
perature, and ionic strength).
Another drug that inhibits kinesin motility
A natural product of the marine sponge Haliclona, adocia-
sulfate-2, inhibits kinesin motility with a mechanism differ-
ent from that of local anesthetics. It targets the kinesin
motor domain by mimicking MT activity and abolishes
kinesin’s binding to a MT in a competitive manner (Sako-
wicz et al., 1998). Therefore, in this case, the MT-stimulated
kinesin ATPase is also inhibited. Two types of kinesin
inhibitors, local anesthetics and adociasulfate-2, are both
useful in various experiments. An advantage of local anes-
thetics over adociasulfate-2 is that they can permeate intact
cell membranes, whereas adociasulfate-2 is membrane im-
permeant because of its large size and two charged sulfate
moieties.
CONCLUSION
We conclude that local anesthetics directly and reversibly
inhibit the MT-based kinesin motility without lowering its
ATPase activity. This action is due to the charged form of
local anesthetics. The charged form of the anesthetic pre-
vents MT-attached kinesin from moving forward, probably
by interfering with the kinesin neck region. The model we
present here imitates the situation in a nerve cell, so that the
direct inhibition of the kinesin motility is the major cause of
the inhibition of FAAT by local anesthetics.
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